Drug Product Development & Manufacturing Services

Scalable solutions for your molecule’s development—from preclinical through commercial drug product formulation, manufacturing, and supply.

You’re in control with flexible, data-driven drug product services.

Achieve your molecule’s next milestone with fit-for-phase drug product formulation and drug product manufacturing services, backed by trusted data and the insight you need to navigate the increasing complexity of small molecule and synthetic peptide therapeutics.

Quotient Sciences streamlines the transitions between each development stage to help you bring your drug product to your next milestone efficiently, with no compromises to safety or quality. 

Scientist at the desk drug manufacturing
Join us for our next webinar
 

Over 30 years of experience

in drug product formulation and drug product manufacturing, at all stages of development.

Join us for our next webinar  
 

Scalable for your program

from smaller batch sizes to support clinical trial materials, up to 500 kg for solid oral dosage forms in commercial drug product. 

Join us for our next webinar
 

Trusted by leading companies

including Fortune 100 large pharmaceutical companies and emerging biotechs.

Expedited pathways for rare disease drug programs
Quotient Sciences helps expertly navigate accelerated CMC pathways, meeting timeline requirements when a product has been granted "Fast Track" or similar expedited review status.

Achieve your molecule’s full potential with our extensive experience in developing & manufacturing drug product

Learn how we can work with you on tailored drug product formulation and manufacturing strategies that are fit-for-phase, backed by trusted data and the insight you need to navigate the increasing complexity of drug development.

Partnering with an experienced pharmaceutical CDMO with the expertise, infrastructure, and agility needed to move your novel therapy forward, faster. Let's discuss your next program.

  • Maximize Efficiency

Our teams utilize a range of technologies alongside proven strategies for navigating development in the most efficient way possible. 

  • Bridge the Gaps

Our focus is always phase-appropriate. That means we personalize support for your drug program today while looking ahead to future milestones. 

  • Stay in Control

Our goal is to keep you on-course as you scale up—from registration to commercial batches and beyond, with capabilities to provide a reliable, continued commercial supply that you can trust.

Meet Our Drug Product Experts

Dr. Asma Patel

VP, Integrated Development Services

Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...

About Asma
Jamie Weishaar

VP, Global Commercial Drug Product

Jamie Weishaar is an experienced business development executive leader specializing in pharmaceutical drug development, including ...

About Jamie
Amit Patel

Senior Director of Technical Services

Amit Patel, Senior Director of Technical Services, has held various technical and operational leadership roles during his 15-year ...

About Amit
Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design, across a broad range of dosage forms and ...

About Robert

Drug Product FAQs

 

Quotient Sciences has multiple U.S. facilities where drug product manufacturing and clinical pharmacology are performed, as well as US-based business development and scientific teams. Quotient Sciences U.S. facilities are located in Boothwyn and Garnet Valley, Pennsylvania (both near Philadelphia in Eastern Pennsylvania) as well as in Miami, Florida. 

From facilities located in the US and UK, Quotient Sciences offers coordinated contract research, development, and manufacturing services (CRO services and CDMO services) as part of one organization. Drug product manufacturing is performed at facilities in Nottingham and Reading, UK, and in the US from our two facilities located near Philadelphia, PA. 

Good Manufacturing Practices (GMP) refer to the guidelines that ensure that pharmaceutical products are produced in a consistent way, maintaining quality standards. Also known as current Good Manufacturing Practices, or cGMP, these practices focus on ensuring safety, quality, and efficacy of drug products over the lifecycle of a drug. Quotient Sciences adheres to cGMP practices at all of our global pharma manufacturing facilities.

A CRDMO is a contract research, development, and manufacturing organization. A company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors. 

Get in touch
Let’s talk about your drug program’s potential.